Universal Ibogaine Inc. (IBOGF)
OTCMKTS · Delayed Price · Currency is USD
0.0132
-0.0009 (-6.07%)
Sep 12, 2025, 11:30 AM EDT
Universal Ibogaine Market Cap
Universal Ibogaine has a market cap or net worth of $4.51 million as of September 12, 2025. Its market cap has increased by 217.79% in one year.
Market Cap
4.51M
Enterprise Value
6.28M
Revenue
1.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since October 5, 2021, Universal Ibogaine's market cap has decreased from 27.27M to 4.51M, a decrease of -83.44%. That is a compound annual growth rate of -36.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 4.51M | 321.00% |
| Dec 31, 2024 | 1.07M | 47.59% |
| Dec 28, 2023 | 726.62K | -65.76% |
| Dec 30, 2022 | 2.12M | -88.73% |
| Dec 31, 2021 | 18.82M | -30.97% |
| Oct 5, 2021 | 27.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 739.21M |
| Elite Pharmaceuticals | 737.49M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |